Anna Maria Nurmi (Anna Nurmi)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 2

Top Topics

Inflammatory Response

Patient Reported

Top Venues

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Maria Nurmi, Jaana Hagström, Harri Mustonen, Hanna Seppänen, Caj Haglund
The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy. PloS one 17 (5) (2022)
Anna Maria Nurmi, Harri Mustonen, Helka Parviainen, Katriina Peltola, Caj Haglund, Hanna Seppänen
Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer. Acta oncologica (Stockholm, Sweden) 57 (6) (2017)